MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0001624
Unidrug Innovative Pharma Technologies Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹44.46 Cr
▲ 28% YoY
Net profit · FY 2025
₹2.09 Cr
Net margin 4.7%
EBITDA · FY 2025
₹4.39 Cr
EBITDA margin 9.9%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹9.58 Cr
Issued & subscribed
Open charges
₹40.49 Cr
Satisfied ₹16.87 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
33
Provident fund records
About Unidrug Innovative Pharma Technologies Limited
Data last updated:
Unidrug Innovative Pharma Technologies Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 March 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85120MP1987PLC003875. Its GSTIN is 23AAACU2220R1ZD (Madhya Pradesh).
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹9.58 Cr. It was formerly known as Uni Drug Ltd and Uni Drug Pvt Ltd. It is led by directors including Jainesh Jain (Managing Director) and Gajanand Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.46 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Cr (net margin 4.7%) and EBITDA of ₹4.39 Cr (EBITDA margin 9.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Unidrug. As per MCA filings, the company has open charges of ₹40.49 Cr and satisfied charges of ₹16.87 Cr on record.
Unidrug Innovative Pharma Technologies Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0001624). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unidrugindia.com.
Company details
CIN U85120MP1987PLC003875
Registration Number 003875
Incorporation Date 13 March 1987
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0001624
Name history
Unidrug Innovative Pharma Technologies has undergone 2 name changes throughout its history. The company was previously known as Uni Drug Ltd, and Uni Drug Pvt Ltd. The current legal name is Unidrug Innovative Pharma Technologies Limited.
| Company Name | Status |
|---|---|
| Unidrug Innovative Pharma Technologies Limited | Current |
| Uni Drug Ltd | Previous |
| Uni Drug Pvt Ltd | Previous |
CIN history
Unidrug Innovative Pharma Technologies has one previous CIN (Corporate Identification Number): L85120MP1987PLC003875. The current CIN is U85120MP1987PLC003875, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85120MP1987PLC003875 | Current |
| L85120MP1987PLC003875 | Previous |
Recognitions & Rankings of Unidrug Innovative Pharma Technologies
Contact details
Unidrug Innovative Pharma Technologies Limited's registered office is in Indore, Madhya Pradesh. Its website is unidrugindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015
- IndustryPharma, API Manufacturers
To see the full contact details of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Comprehensive company report
Unidrug Innovative Pharma Technologies Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Unidrug Innovative Pharma Technologies operates one associated brand: Unidrug. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API development, manufacturing, and marketing with global exports from India. | unidrugindia.com |
Business activity
The main business activity of Unidrug Innovative Pharma Technologies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Financials of Unidrug Innovative Pharma Technologies Limited
FY 2025 filings availableUnidrug Innovative Pharma Technologies Limited reported revenue of ₹44.46 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹44.46 Cr ▲ 28%
Net profit · FY 2025
₹2.09 Cr margin 4.7%
EBITDA · FY 2025
₹4.39 Cr margin 9.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 66%
3 years · compounded
▼ 10%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 28% growth in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.9% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Board of directors of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jainesh Jain Also directs: T.K.Estates Pvt Ltd | Managing Director | 20 Aug 1995 | 31 Years 2 Months | Current |
| Gajanand Agrawal | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Bharat Jain | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Varsha Jain | Director | 05 Oct 1995 | 31 Years 0 Months | Current |
Peer comparison
Unidrug Innovative Pharma Technologies Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Concord Drugs Limited | ₹45.26 Cr (FY 2025) | 1.0% | Telangana, India | |||
| Raghava Life Sciences Private Limited | ₹45.14 Cr (FY 2025) | -26.0% | Hyderabad, Telangana, India | |||
| S.V.Chem Intermediates Private Limited | ₹44.99 Cr (FY 2025) | -11.0% | Thiruporur, Tamil Nadu, India | |||
| FR Chem Private Limited | ₹44.47 Cr (FY 2025) | 59.0% | Ahmedabad, Gujarat, India | |||
| Unidrug Innovative Pharma Technologies Limitedthis company | ₹44.46 Cr (FY 2025) | ₹2.09 Cr | 4.7% | 28.0% | 33 | Indore, Madhya Pradesh, India |
| S.V.R. Laboratories Private Limited | ₹44.45 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India | |||
| TCG Greenchem Manufacturing Private Limited | ₹44.39 Cr (FY 2025) | -17.0% | Kolkata, West Bengal, India | |||
| Panvo Organics Private Limited | ₹44.09 Cr (FY 2024) | 0.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Auditor
Unidrug Innovative Pharma Technologies Limited is audited by S N GADIYA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S N GADIYA & CO. | FY 2023 | 02052C |
Shareholding
The shareholding of Unidrug Innovative Pharma Technologies Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Charges & borrowings
Open charges
₹40.49 Cr
Satisfied charges
₹16.87 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Oct 2024 | 100999369 | Others | ₹15 Lakh | Open | |
| 29 Jan 2024 | 100861674 | Others | ₹25 Lakh | Open | |
| 21 Nov 2023 | 100829589 | Others | ₹15 Lakh | Open | |
| 03 Jul 2020 | 100351929 | Others | ₹67 Lakh | Open | |
| 28 Apr 2017 | 100097545 | Others | ₹39.27 Cr | Open |
To see the full charge records of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Total charge records: 16 View all charges
Legal cases
No court or tribunal cases involving Unidrug Innovative Pharma Technologies Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unidrug Innovative Pharma Technologies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unidrug Innovative Pharma Technologies Limited has a workforce of 33 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
33
Active EPFO establishments
1
Employee growth
-5.71%
GST
Unidrug Innovative Pharma Technologies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACU2220R1ZD | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unidrug Innovative Pharma Technologies Limited, buy the company report.
Recent activity
Unidrug Innovative Pharma Technologies Limited has 15 board changes on record since 1995: 5 appointments and 10 cessations. The latest: Mahesh Asawa Chandra ceased to be Director on 10 Apr 2021.
Charges
A charge with Others of Rs. 39.27 Cr registered on 28 Apr 2017 with Charge ID 100097545 was modified on 17 Oct 2025.
AGM
Unidrug Innovative Pharma Technologies Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unidrug Innovative Pharma Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100999369 was registered on 15 Oct 2024.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100861674 was registered on 29 Jan 2024.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100829589 was registered on 21 Nov 2023.
Charges
A charge registered on 15 Oct 2018 via Charge ID 100278299 with State Bank Of India was fully satisfied on 21 Oct 2022.
Ceased
Mahesh Asawa Chandra ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.67 Cr with Charge ID 100351929 was registered on 03 Jul 2020.
Charges
A charge with Others of Rs. 0.67 Cr registered on 03 Jul 2020 with Charge ID 100351929 was modified on 03 Jul 2020.
Ceased
Anamika Runwal ceased to be Company Secretary.
Ceased
Bharat Jain ceased to be Additional Director.
40 earlier events are in the company report.
Frequently asked questions
Unidrug Innovative Pharma Technologies is an active public limited company based in Indore, Madhya Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 13 March 1987 (39+ years old) and is registered under CIN U85120MP1987PLC003875.
Unidrug Innovative Pharma Technologies has 4 current directors:
- Jainesh Jain - Managing Director
- Gajanand Agrawal - Director
- Bharat Jain - Director
- Varsha Jain - Director
The latest financial statements of Unidrug Innovative Pharma Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unidrug Innovative Pharma Technologies is 23AAACU2220R1ZD, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Unidrug Innovative Pharma Technologies is U85120MP1987PLC003875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unidrug Innovative Pharma Technologies was incorporated on 13 March 1987, making it 39+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Unidrug Innovative Pharma Technologies by revenue are Concord Drugs Limited, Raghava Life Sciences Private Limited, S.V.Chem Intermediates Private Limited, FR Chem Private Limited, S.V.R. Laboratories Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahesh Asawa Chandra ceased to be Director on 10 Apr 2021. Anamika Runwal ceased to be Company Secretary on 01 Apr 2020. Bharat Jain ceased to be Additional Director on 23 Aug 2019. Unidrug Innovative Pharma Technologies has 15 board changes on record in total.
Yes, Unidrug Innovative Pharma Technologies is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0001624).
Unidrug Innovative Pharma Technologies can be reached through the website unidrugindia.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Unidrug Innovative Pharma Technologies is at Plot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages